Concepedia

R.S.K. Vijayan

RV

Statistics

Publications

3

Citations

744

H-Index

3

Active since

2019

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Foundation Medicine (United States)

Guardant (United States)

R.S.K. Vijayan is an author at The University of Texas MD Anderson Cancer Center specializing in radiation oncology, cancer biology, and tumor biology.

Top concepts

Publications per year

2019–2022

3

Publications

3

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Jacqulyne Robichaux, Xiuning Le, R.S.K. Vijayan et al. · Nature · 2021 · 416 citations · Full text

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

Jacqulyne Robichaux, Yasir Y. Elamin, R.S.K. Vijayan et al. · Cancer Cell · 2019 · 226 citations · Full text

, , +9

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

Yasir Y. Elamin, Jacqulyne Robichaux, Brett W. Carter et al. · Cancer Cell · 2022 · 102 citations · Full text

1–3 of 3